Long Read Sequencing Market Size, Growth, Trends, Report 2027

Report Description

The global long read sequencing market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include growing occurrences of genetic disorders, growing government support for R&D activities and extensive development in technology are fueling the growth of the market. Long-read sequencing, also known as third-generation sequencing, is a DNA sequencing technique which is being researched. It can determine the nucleotide sequence of long sequences of DNA ranging between 10,000 and 100,000 base pairs at a time. This technology eliminates the need to cut up and then amplify DNA which is usually needed in other DNA sequencing methods. The other factors supporting the market’s growth are, rise in R&D activities, growing number of patients with genetic diseases including cancer, increasing number of clinical trials, rising popularity of personalized medicine, increasing acceptance of modern approaches for medical diagnostics, rising utilization of sequence analysis methodologies in medical institutes for academic purposes, rise in world population, growing adoption of inorganic growth strategies, and immense potential for emerging submarkets.

Surge in Incidences of Genetic Disorders

The increasing prevalence of genetic diseases such as color blindness, Down’s syndrome, cystic fibrosis, and others, across the globe are bolstering the growth of the market. According to the World Health Organization (WHO), more than 10,000 of the diseases are known to be monogenic triggered by single error in a single gene in the human DNA. With the help of long read sequencing methods, the whole genomics of the patient can be examined. Thus, rising the adoption of long-read sequencing in treatment of genetic conditions. The growing number of patients suffering from genetic diseases is also a contributing factor for the growth of the market. According to the World Health Organization (WHO), sickle cell anemia, a severe genetic condition, affects about 72,000 new-born babies.

Increasing Government Support for R&D Activities

The increasing research which uses long read sequencing methods are being heavily funded from government authorities, which is a key reason for the growth of the market. Moreover, rising number of research activities is augmenting the growth of the market. For instance, in the U.S., genomics research and development projects are funded through the National Institutes of Health (NIH) as well as numerous other groups from around the globe. Presently, numerous amounts of research activities are being performed which is projected to give manufacturers an advantage as they develop new and advanced long read sequencing, as well as to open many opportunities in the long read sequencing market. For instance, in the U.S., genomics research and development projects are funded through the National Institutes of Health (NIH) as well as numerous other groups from around the globe.

Technological advancements

Rise in technological advancements in sequencers are propelling the growth of the market. These advancements have made sequencing more efficient, accurate, and portable. For instance, long reads generated by SMRT sequencers span around possible repetitive regions and give a comprehensive view of the whole genome. Similarly, in 2018, Pacific Biosciences of California (PacBio) announced the enhancements to their Sequel System, which comprises of a new version of its software, new consumables including reagents, and a new SMRT Cell (1M v3).

Download Free Sample Report

Market Segmentation

The global long read sequencing market is segmented into component, technology, workflow, application, end user, and company. Based on component, the market is divided into instruments, consumables, and services. Based on technology, the market is divided into single-molecule real-time sequencing (SMRT), nanopore sequencing, and others. Based on workflow, the market is divided into pre-sequencing, sequencing, and data analysis. Based on application, the market is divided into oncology, infectious diseases, rare diseases, genetic disorders, metabolic disorders, and others. Based on end user, the market is divided into hospitals & clinics, biotechnology & pharmaceutical companies, academic & research institutions, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due rising incidences of hematologic malignancies in the country.

Market Players

Agilent Technologies, Inc., BGI Group, Bionano Genomics, Inc., Circulomics Inc, Oxford Nanopore Technologies plc, Longas Technologies Pty Ltd, Novogene Co., Ltd., Illumina, Inc., F. Hoffmann-La Roche AG, Pacific Biosciences of California, Inc., Quantapore, Inc., QIAGEN NV, PerkinElmer, Inc, Thermo Fischer Scientific, Inc., and Takara Bio, Inc. are some of the leading companies operating in the market.

Attribute	Details
Base Year	2021
Historic Data	2017 – 2020
Estimated Year	2022
Forecast Period	2023 – 2027
Quantitative Units	Revenue in USD Million, Volume Units and CAGR for 2017-2021 and 2022-2027
Report coverage	Revenue forecast, Volume forecast company share, competitive landscape, growth factors, and trends
Segments covered	· Component · Technology · Workflow · Application · End User · Company
Regional scope	North America; Asia Pacific; Europe & CIS; South America; Middle East & Africa
Country scope	United States; Canada; Mexico; China; India; Japan; South Korea; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Colombia; South Africa; UAE; Saudi Arabia; South Africa;
Key companies profiled	Agilent Technologies, Inc., BGI Group, Bionano Genomics, Inc., Circulomics Inc, Oxford Nanopore Technologies plc, Longas Technologies Pty Ltd, Novogene Co., Ltd., Illumina, Inc., F. Hoffmann-La Roche AG, Pacific Biosciences of California, Inc., Quantapore, Inc., QIAGEN NV, PerkinElmer, Inc, Thermo Fischer Scientific, Inc., and Takara Bio, Inc.
Customization scope	10% free report customization with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, global long read sequencing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

· Long Read Sequencing Market, By Component:

o Instruments

o Consumables

o Services

· Long Read Sequencing Market, By Technology:

o Single-Molecule Real-Time Sequencing (SMRT)

o Nanopore Sequencing

o Others

· Long Read Sequencing Market, By Workflow:

Pre-Sequencing
Sequencing
Data Analysis

· Long Read Sequencing Market, By Application:

o Oncology

o Infectious Diseases

o Rare Diseases

o Genetic Disorders,

o Metabolic Disorders

o Others

· Long Read Sequencing Market, By End User:

o Hospitals & Clinics

o Biotechnology & Pharmaceutical Companies,

o Academic & Research Institutions

o Others

· Long Read Sequencing Market, By Region:

North America

United States
Canada
Mexico

Asia-Pacific

China
India
Japan
Australia
South Korea

Europe & CIS

Germany
France
United Kingdom
Spain
Italy

South America

Brazil
Argentina
Colombia

Middle East & Africa

§ South Africa

§ Saudi Arabia

§ UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Long Read Sequencing Market

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Long Read Sequencing Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Long Read Sequencing Market

4. Voice of Customer

5. Executive Summary

6. Global Long Read Sequencing Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Component (Instruments, Consumables, Services)

6.2.2. By Technology (Single-Molecule Real-Time Sequencing (SMRT), Nanopore Sequencing, Others)

6.2.3. By Workflow (Pre-Sequencing, Sequencing, Data Analysis)

6.2.4. By Application (Oncology, Infectious Diseases, Rare Diseases, Genetic Disorders, Metabolic Disorders, Others)

6.2.5. By End User (Hospitals & Clinics, Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others)

6.2.6. By Region

6.2.7. By Company (2021)

6.3. Market Map

7. North America Long Read Sequencing Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Component

7.2.2. By Technology

7.2.3. By Workflow

7.2.4. By Application

7.2.5. By End User

7.2.6. By Country

7.3. North America: Country Analysis

7.3.1. United States Long Read Sequencing Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Component

7.3.1.2.2. By Technology

7.3.1.2.3. By Workflow

7.3.1.2.4. By Application

7.3.1.2.5. By End User

7.3.2. Mexico Long Read Sequencing Market Outlook

7.3.2.1. Market Size & Forecast

7.3.2.1.1. By Value

7.3.2.2. Market Share & Forecast

7.3.2.2.1. By Component

7.3.2.2.2. By Technology

7.3.2.2.3. By Workflow

7.3.2.2.4. By Application

7.3.2.2.5. By End User

7.3.3. Canada Long Read Sequencing Market Outlook

7.3.3.1. Market Size & Forecast

7.3.3.1.1. By Value

7.3.3.2. Market Share & Forecast

7.3.3.2.1. By Component

7.3.3.2.2. By Technology

7.3.3.2.3. By Workflow

7.3.3.2.4. By Application

7.3.3.2.5. By End User

8. Europe Long Read Sequencing Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Component

8.2.2. By Technology

8.2.3. By Workflow

8.2.4. By Application

8.2.5. By End User

8.2.6. By Country

8.3. Europe: Country Analysis

8.3.1. France Long Read Sequencing Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1. By Component

8.3.1.2.2. By Technology

8.3.1.2.3. By Workflow

8.3.1.2.4. By Application

8.3.1.2.5. By End User

8.3.2. Germany Long Read Sequencing Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1. By Component

8.3.2.2.2. By Technology

8.3.2.2.3. By Workflow

8.3.2.2.4. By Application

8.3.2.2.5. By End User

8.3.3. United Kingdom Long Read Sequencing Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1. By Component

8.3.3.2.2. By Technology

8.3.3.2.3. By Workflow

8.3.3.2.4. By Application

8.3.3.2.5. By End User

8.3.4. Italy Long Read Sequencing Market Outlook

8.3.4.1. Market Size & Forecast

8.3.4.1.1. By Value

8.3.4.2. Market Share & Forecast

8.3.4.2.1. By Component

8.3.4.2.2. By Technology

8.3.4.2.3. By Workflow

8.3.4.2.4. By Application

8.3.4.2.5. By End User

8.3.5. Spain Long Read Sequencing Market Outlook

8.3.5.1. Market Size & Forecast

8.3.5.1.1. By Value

8.3.5.2. Market Share & Forecast

8.3.5.2.1. By Component

8.3.5.2.2. By Technology

8.3.5.2.3. By Workflow

8.3.5.2.4. By Application

8.3.5.2.5. By End User

9. Asia-Pacific Long Read Sequencing Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Component

9.2.2. By Technology

9.2.3. By Workflow

9.2.4. By Application

9.2.5. By End User

9.2.6. By Country

9.3. Asia-Pacific: Country Analysis

9.3.1. China Long Read Sequencing Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1. By Component

9.3.1.2.2. By Technology

9.3.1.2.3. By Workflow

9.3.1.2.4. By Application

9.3.1.2.5. By End User

9.3.2. India Long Read Sequencing Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1. By Component

9.3.2.2.2. By Technology

9.3.2.2.3. By Workflow

9.3.2.2.4. By Application

9.3.2.2.5. By End User

9.3.3. Japan Long Read Sequencing Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1. By Component

9.3.3.2.2. By Technology

9.3.3.2.3. By Workflow

9.3.3.2.4. By Application

9.3.3.2.5. By End User

9.3.4. South Korea Long Read Sequencing Market Outlook

9.3.4.1. Market Size & Forecast

9.3.4.1.1. By Value

9.3.4.2. Market Share & Forecast

9.3.4.2.1. By Component

9.3.4.2.2. By Technology

9.3.4.2.3. By Workflow

9.3.4.2.4. By Application

9.3.4.2.5. By End User

9.3.5. Australia Long Read Sequencing Market Outlook

9.3.5.1. Market Size & Forecast

9.3.5.1.1. By Value

9.3.5.2. Market Share & Forecast

9.3.5.2.1. By Component

9.3.5.2.2. By Technology

9.3.5.2.3. By Workflow

9.3.5.2.4. By Application

9.3.5.2.5. By End User

10. South America Long Read Sequencing Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Component

10.2.2. By Technology

10.2.3. By Workflow

10.2.4. By Application

10.2.5. By End User

10.2.6. By Country

10.3. South America: Country Analysis

10.3.1. Brazil Long Read Sequencing Market Outlook

10.3.1.1. Market Size & Forecast

10.3.1.1.1. By Value

10.3.1.2. Market Share & Forecast

10.3.1.2.1. By Component

10.3.1.2.2. By Technology

10.3.1.2.3. By Workflow

10.3.1.2.4. By Application

10.3.1.2.5. By End User

10.3.2. Argentina Long Read Sequencing Market Outlook

10.3.2.1. Market Size & Forecast

10.3.2.1.1. By Value

10.3.2.2. Market Share & Forecast

10.3.2.2.1. By Component

10.3.2.2.2. By Technology

10.3.2.2.3. By Workflow

10.3.2.2.4. By Application

10.3.2.2.5. By End User

10.3.3. Colombia Long Read Sequencing Market Outlook

10.3.3.1. Market Size & Forecast

10.3.3.1.1. By Value

10.3.3.2. Market Share & Forecast

10.3.3.2.1. By Component

10.3.3.2.2. By Technology

10.3.3.2.3. By Workflow

10.3.3.2.4. By Application

10.3.3.2.5. By End User

11. Middle East and Africa Long Read Sequencing Market Outlook

11.1. Market Size & Forecast

11.1.1. By Value

11.2. Market Share & Forecast

11.2.1. By Component

11.2.2. By Technology

11.2.3. By Workflow

11.2.4. By Application

11.2.5. By End User

11.2.6. By Country

11.3. MEA: Country Analysis

11.3.1. South Africa Long Read Sequencing Market Outlook

11.3.1.1. Market Size & Forecast

11.3.1.1.1. By Value

11.3.1.2. Market Share & Forecast

11.3.1.2.1. By Component

11.3.1.2.2. By Technology

11.3.1.2.3. By Workflow

11.3.1.2.4. By Application

11.3.1.2.5. By End User

11.3.2. Saudi Arabia Long Read Sequencing Market Outlook

11.3.2.1. Market Size & Forecast

11.3.2.1.1. By Value

11.3.2.2. Market Share & Forecast

11.3.2.2.1. By Component

11.3.2.2.2. By Technology

11.3.2.2.3. By Workflow

11.3.2.2.4. By Application

11.3.2.2.5. By End User

11.3.3. UAE Long Read Sequencing Market Outlook

11.3.3.1. Market Size & Forecast

11.3.3.1.1. By Value

11.3.3.2. Market Share & Forecast

11.3.3.2.1. By Component

11.3.3.2.2. By Technology

11.3.3.2.3. By Workflow

11.3.3.2.4. By Application

11.3.3.2.5. By End User

12. Market Dynamics

12.1. Drivers

12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

14.1. Agilent Technologies, Inc.

14.2. BGI Group

14.3. Bionano Genomics, Inc.

14.4. Circulomics Inc

14.5. Oxford Nanopore Technologies plc

14.6. Longas Technologies Pty Ltd

14.7. Novogene Co., Ltd.

14.8. Illumina, Inc.

14.9. F. Hoffmann-La Roche AG

14.10. Pacific Biosciences of California, Inc.

14.11. Quantapore, Inc.

14.12. QIAGEN NV

14.13. PerkinElmer, Inc

14.14. Thermo Fischer Scientific, Inc.

14.15. Takara Bio, Inc.

15. Strategic Recommendations

Figures and Tables

Frequently asked questions

What are the major drivers for the Global Long Read Sequencing Market?

Growing incidence of genetic diseases, rising government support, and rising technological advancements are driving the demand for the global long read sequencing market.

Who are the top players operating in the global Long Read Sequencing market?

Agilent Technologies, Inc., BGI Group, Bionano Genomics, Inc., Circulomics Inc, Oxford Nanopore Technologies plc, Longas Technologies Pty Ltd, Novogene Co., Ltd., Illumina, Inc., F. Hoffmann-La Roche AG, Pacific Biosciences of California, Inc., Quantapore, Inc., QIAGEN NV, PerkinElmer, Inc, Thermo Fischer Scientific, Inc., and Takara Bio, Inc. are the key players operating in the global long read sequencing market.

What are the key factors hampering growth for the Global Long Read Sequencing Market?

The lack of high complexity genomic testing centers in high potential markets, challenges pertaining to genomic data centers, and scarcity of knowledge dissemination pertaining to advanced diagnostic capabilities may hamper the growth of the global long read sequencing market.